COMPLETE AND PARTIAL-RESPONSE (CR, PR) IN TREATMENT OF ADVANCED REFRACTORY B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) USING CAMPATH-1H

被引：0
|
作者：
JANSON, D [1 ]
NISSELHOROWITZ, S [1 ]
SATTLER, M [1 ]
RAI, KR [1 ]
机构：
[1] LONG ISL JEWISH MED CTR,DIV HEMATOL ONCOL,NEW HYDE PK,NY 11042
来源：
BLOOD | 1993年 / 82卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A139 / A139
页数：1
相关论文
共 50 条
  • [41] CYTOGENETIC EVIDENCE FOR CLONAL EVOLUTION IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL)
    HAN, T
    OZER, H
    SADAMORI, N
    OHTAKI, K
    BLOCK, AW
    DADEY, B
    GOMEZ, GA
    HENDERSON, ES
    SANDBERG, AA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 160 - 160
  • [42] THE BCL-1 SEQUENCES LOCATED AT 11Q13 ARE TRANSCRIPTIONALLY ACTIVE IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL)
    VADHANRAJ, S
    BLICK, M
    SELVANAYAGAM, P
    TSUJIMOTO, Y
    FORD, R
    KANTARJIAN, H
    GUTTERMAN, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 20 - 20
  • [43] THE ORIGIN OF B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) AND ITS RELATIONSHIP TO HAIRY-CELL LEUKEMIA (HCL)
    CALIGARISCAPPIO, F
    BERGUI, L
    PIZZOLO, G
    CHILOSI, M
    TESIO, L
    CAMPANA, D
    SEMENZATO, G
    MALAVASI, F
    GOBBI, M
    ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, 1985, 186 : 949 - 956
  • [44] ADVANCES IN THE BIOLOGY AND TREATMENT OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
    OBRIEN, S
    DELGIGLIO, A
    KEATING, M
    BLOOD, 1995, 85 (02) : 307 - 318
  • [45] TREATMENT OF ANEMIA IN B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO)
    PANGALIS, GA
    POZIOPOULOS, C
    PANAYIOTIDIS, P
    ANGELOPOULOU, M
    BLOOD, 1993, 82 (10) : A574 - A574
  • [46] HETEROGENEOUS RESPONSE OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) CELLS TO ANTI-HUMAN IGM ANTIBODY (ANTI-MU) AND B-CELL STIMULATORY FACTOR 1 (BSF-1)
    KAWANO, M
    IWATO, K
    ASAOKU, H
    TANABE, O
    TANAKA, H
    ISHIKAWA, H
    IMAMURA, N
    KURAMOTO, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1989, 71 (01) : 47 - 51
  • [47] Clinical significance of CD69 expression in B-cell Chronic Lymphocytic Leukemia (B-CLL)
    Del Poeta, G.
    Del Principe, M., I
    Luciano, F.
    Maurillo, L.
    Buccisano, F.
    Gattei, V
    Niscola, P.
    Venditti, A.
    Imo Consalvo, M.
    Catalano, G.
    de Fabritiis, P.
    Amadori, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 108 - 108
  • [48] Prognostic relevance of CD38 expression in B-cell chronic lymphocytic leukemia (B-CLL)
    D'Arena, G.
    Napolitano, M.
    Marcacci, G.
    Russo, F.
    Vigliotti, M. L.
    Mauro, F.
    Corazzelli, G.
    Frigeri, F.
    Della Cioppa, P.
    Svanera, G.
    Capobianco, G.
    Nasuti, A.
    Villani, O.
    Pinto, A.
    CYTOMETRY PART A, 2006, 69A (05) : 449 - 449
  • [49] IN-VITRO SENSITIVITY TO CAMPTOTHECINS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) WITH AND WITHOUT P53-GENE MUTATION
    COSTIN, D
    POTMESIL, M
    NEWCOMB, EW
    ELROUBY, S
    THOMAS, A
    DRYGAS, J
    MORSE, L
    SILBER, R
    BLOOD, 1993, 82 (10) : A43 - A43
  • [50] Maintenance therapy with a monthly injection of alemtuzumab prolongs response duration in patients with refractory B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL)
    Thieblemont, C
    Bouafia, F
    Hornez, E
    Dumontet, C
    Tartas, S
    Antal, D
    Lemieux, B
    Traullé, C
    Espinouse, D
    Salles, G
    Coiffier, B
    LEUKEMIA & LYMPHOMA, 2004, 45 (04) : 711 - 714
12345